Dexcom Inc DXCM

NAS: DXCM | ISIN: US2521311074   5/12/2025
65,49 USD (+0,37%)
(+0,37%)   5/12/2025

5 december 2025 · Levi & Korsinsky Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 26, 2025 - DXCM · Persbericht

2 december 2025 · Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom Lawsuit - DXCM · Persbericht

25 november 2025 · Shareholders that lost money on DexCom, Inc.(DXCM) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More · Persbericht

24 november 2025 · Ademi & Fruchter LLP Investigates Claims of Securities Fraud against DexCom, Inc. · Persbericht

22 november 2025 · DXCM Announcement: Kessler Topaz Meltzer & Check, LLP Encourages DexCom, Inc. (DXCM) Investors to Contact the Firm About Securities Fraud Class Action Lawsuit · Persbericht

21 november 2025 · Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. Lawsuit - DXCM · Persbericht

17 november 2025 · DXCM Announcement: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against DexCom, Inc. (DXCM) · Persbericht

14 november 2025 · Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. Lawsuit - DXCM · Persbericht

13 november 2025 · DexCom, Inc. (DXCM) Investors: December 26, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP · Persbericht

11 november 2025 · Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately · Persbericht

11 november 2025 · Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. Lawsuit - DXCM · Persbericht

7 november 2025 · DexCom, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 26, 2025 to Discuss Your Rights - DXCM · Persbericht

15 juli 2025 · Artificial Intelligence Revolutionizing Early Detection of Diabetic Retinopathy Creating a Multi-Billion Dollar Revenue Opportunity · Persbericht

13 september 2024 · DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm · Persbericht

13 september 2024 · Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 21, 2024 in DexCom, Inc. Lawsuit - DXCM · Persbericht

12 september 2024 · INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DexCom · Persbericht

11 september 2024 · Kessler Topaz Meltzer & Check, LLP Reminds DXCM Investors of October 21, 2024 Deadline in Securities Fraud Class Action and Urges Investors with Losses to Contact the Firm · Persbericht

10 september 2024 · Shareholders that lost money on DexCom, Inc.(DXCM) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More · Persbericht

7 september 2024 · DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit · Persbericht

6 september 2024 · Investors who lost money on DexCom, Inc.(DXCM) should contact Levi & Korsinsky about pending Class Action - DXCM · Persbericht

Mijn selecties